A SURPASS-4 clinical trial involved patients with cardiovascular diseases such as peripheral arterial disease, coronary artery disease, stroke, and myocardial infarction
Gut-brain axis investigations: Researched for roles in appetite control and central nervous system signaling
If necessary, however, Wegovy can be kept at room temperature for up to 28 days
References 1 New England Journal of Medicine REDEFINE 1Garvey WT et al
In clinical trials, 86% of non-diabetic patients receiving once-weekly semaglutide injections lost at least 5% of their body weight.[8] Ozempic : Ozempic is a once-weekly subcutaneous injection approved for patients with T2D, though it is sometimes prescribed off-label for weight loss.[9] It is used alongside diet and exercise to improve glycemic control and reduce cardiovascular risk in adults with T2D
Braz J Med Biol Res 2018;51:e7299.ArticlePubMedPMC 105